Skip to main content
UFPT
NASDAQ Industrial Applications And Services

UFP Technologies Reports Record Q2: Revenue +15%, EPS $2.92, Margins Expand

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$267.53
Mkt Cap
$2.07B
52W Low
$173.86
52W High
$279.49
52W Position info
54% above low
Off High info
4.3% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

UFPT sits 54% above its 52-week low of $173.86.

Summary

UFP Technologies posted record Q2 results with revenue of $174 million (+15% YoY) and adjusted EPS of $2.92, beating consensus estimates. Gross margins expanded, and adjusted EBITDA grew 14%, reflecting strong MedTech demand and operational execution.


Key Events · Earnings and Guidance · UFPT

  • Record Q2 Revenue and Earnings

    Net sales rose 15.1% to $174.0 million, net income increased 21.4% to $20.9 million, and adjusted diluted EPS reached $2.92, all quarterly records.

  • Gross Margin Expansion

    Gross margin improved to 29.3% from 28.8% a year ago, driven by operating leverage and favorable mix.

  • Organic Growth Accelerates

    Organic sales growth was 12.4% in Q2, up from 6.8% in the first half, with the balance of MedTech business growing 19.7%.

  • SG&A Investments Pressure Margins

    SG&A rose to 13.1% of sales from 12.4%, reflecting investments in Dominican Republic operations and leadership hires, which management noted are creating near-term margin pressure.


Analysis · UFPT · Industrial Applications And Services

UFP Technologies delivered a standout second quarter, with revenue surging 15% to $174 million, well above the $159 million consensus, and adjusted EPS of $2.92 beating estimates by a wide margin. Gross margins expanded to 29.3%, and adjusted EBITDA jumped 14% to $36.4 million. The results underscore strong execution across its MedTech platform, with organic growth of 12.4% and broad-based strength beyond its top customers. While SG&A rose as a percentage of sales due to investments in the Dominican Republic and leadership hires, the margin expansion and record profitability signal that the company is successfully scaling its operations. The stock is trading near its 52-week high, and these results validate the premium valuation, though the near-term margin pressure from the Dominican Republic ramp and elevated SG&A bear watching.

At the time of this filing, UFPT was trading at $267.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $173.86 to $279.49. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UFPT - Latest Insights

UFPT
Aug 03, 2026, 4:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $267.53
Real-time Price: $267.53 info
Change: $0 (0%) info
Market Cap: $2.07B info
UFPT
Jun 10, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $232.48
Real-time Price: $267.53 info
Change: +$35.05 (+15%) info
Market Cap: $2.07B info
UFPT
May 08, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $230.55
Real-time Price: $267.53 info
Change: +$36.98 (+16%) info
Market Cap: $2.07B info
UFPT
May 04, 2026, 4:56 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $192.55
Real-time Price: $267.53 info
Change: +$74.98 (+39%) info
Market Cap: $2.07B info
UFPT
Apr 30, 2026, 12:40 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $190.89
Real-time Price: $267.53 info
Change: +$76.64 (+40%) info
Market Cap: $2.07B info